Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,670.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,744.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 75,638
  • Market Cap: £3,728.93m
  • RiskGrade: 128

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 25 Feb 2021

LONDON (ShareCast) - (Sharecast News) - Medica Group: Liberum initiates at buy with a target price of 200p.



Reckitt Benckiser: Berenberg reiterates buy with a target price of 8,385p.

Lloyds Banking Group: Berenberg reiterates hold with a target price of 38p.

Grafton Group: Canaccord reiterates buy with a target price of 1,010p.

easyJet: Deutsche Bank reiterates buy with a target price of 1,000p.

Wizz Air: Deutsche Bank reiterates buy with a target price of 5,650p.

Biffa: Peel Hunt reiterates hold with a target price of 240p.

Genus: Peel Hunt reiterates buy with a target price of 5,500p.

Shaftesbury: Liberum reiterates hold with a target price of 565p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 5,670.00p
Change Today 5.00p
% Change 0.09 %
52 Week High 6,070.00
52 Week Low 3,744.00
Volume 75,638
Shares Issued 65.77m
Market Cap £3,728.93m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average99.62% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average66.67% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income
64.35% below the market average64.35% below the market average64.35% below the market average64.35% below the market average64.35% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 21-Sep-2021

Time Volume / Share Price
16:35 28,594 @ 5,670.00p
16:29 5 @ 5,655.00p
16:29 1 @ 5,660.00p
16:29 25 @ 5,650.00p
16:29 29 @ 5,655.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page